Your browser doesn't support javascript.
loading
Tolerability of twice-weekly rifabutin-isoniazid combinations versus daily isoniazid for latent tuberculosis in HIV-infected subjects: a pilot study.
Matteelli, A; Olliaro, P; Signorini, L; Cadeo, G; Scalzini, A; Bonazzi, L; Caligaris, S; Tomasoni, L; Tebaldi, A; Carosi, G.
Affiliation
  • Matteelli A; Clinic of Infectious and Tropical Diseases, University of Brescia, Italy. forleo@master.cci.unibs.it
Int J Tuberc Lung Dis ; 3(11): 1043-6, 1999 Nov.
Article in En | MEDLINE | ID: mdl-10587327
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / AIDS-Related Opportunistic Infections / Rifabutin / Isoniazid / Antibiotics, Antitubercular / Antitubercular Agents Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Humans Language: En Journal: Int J Tuberc Lung Dis Year: 1999 Document type: Article Affiliation country: Italia
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / AIDS-Related Opportunistic Infections / Rifabutin / Isoniazid / Antibiotics, Antitubercular / Antitubercular Agents Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Humans Language: En Journal: Int J Tuberc Lung Dis Year: 1999 Document type: Article Affiliation country: Italia